20/20 Biolabs Inc. ( AIDX) - Key Metrics
AIDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.14 | -$0.06 | -$0.06 |
| 2026Q1 | $0.03 | -$0.20 | -$0.12 | -$0.12 |
| 2025Q4 | $0.05 | -$0.13 | -$0.05 | -$0.05 |
| 2025Q3 | $0.09 | -$0.17 | -$0.08 | -$0.08 |
| 2025Q2 | $0 | $0 | $0 | $0 |
AIDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -4.48% | -0.53 |
| 2026Q1 | -2.49% | -2.35 |
| 2025Q4 | 0% | -45.87 |
| 2025Q3 | 0% | -35.07 |
| 2025Q2 | 0% | 0 |
AIDX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -10.12% | 1.14% |
| 2026Q1 | -6.46% | 0.27% |
| 2025Q4 | -0.21% | 0% |
| 2025Q3 | -0.33% | 0% |
| 2025Q2 | 0% | 0% |
AIDX
Price: $0.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.58 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 4.7 million